QXO Insulation, LLC
Customers
0
None disclosed
Suppliers
2
2 disclosed
Top supplier share
95%
of QUESTCOR PHARMACEUTICALS INC revenue · FY to 2013-12-31
Top supplier by $
$759.0M
QUESTCOR PHARMACEUTICALS INC · FY to 2013-12-31
Latest period
Dec 31, 2025
10-K filed 2026-02-24
Suppliers 2
Companies that disclose QXO Insulation, LLC as a major customer, as a share of their own revenue. 2 active, 0 lapsed.
| Company | % of their revenue | Est. $ from QXO Insulation, LLC | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| QUESTCOR PHARMACEUTICALS INC QUESTCOR PHARMACEUTICALS INC |
95% | $759.0M | FY 2013-12-31 | −5.0pp | Active | 10-K 2014-02-26 |
Specialty distributor 95 % 100 % 100 % Specialty distributor 92 % 100 % | ||||||
| CORT CORCEPT THERAPEUTICS INC |
1% | $7.6M | FY 2025-12-31 | ±0.0pp | Active | 10-K 2026-02-24 |
From 2017 until 2025, we used an exclusive specialty pharmacy vendor, Optime Care, Inc. (“Optime”) and a specialty distributor to distribute our Products and provide logistical support to physicians and patients. Net Product Revenue – Net product revenue is gross product revenue from sales to our customers less deductions for estimated government rebates and chargebacks, patient co-pay assistance program, discounts provided to our specialty distributor for prompt payment and reserves for expected returns. Net Product Revenue – Net product revenue is gross product revenue from sales to our customers less deductions for estimated government rebates and chargebacks, patient co-pay assistance program, discounts provided to our specialty distributor for prompt payment and reserves for expected returns. | ||||||
Alerts are coming
Get an email when QXO Insulation, LLC's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.